ResearcherJohns Hopkins UniversityActive in the last 2 years
Elizabeth Abou Diwan
Matched on ORCID iD 0009-0007-4264-9982; OpenAlex author ID A5044987088. Sources: OpenAlex.
Their work
- Papers
- 4
- Trials
- 0
- Grants
- 0
- Labs led
- 0
- Collaborators
- 27
2024: 2 papers · 2025: 1 paper · 2026: 1 paper
Papers 4
- First-in-human testing of a mutant KRAS vaccine for pancreatic cancer interception in high-risk cohorts. Co-author DOI 10.1158/2159-8290.cd-25-2245↗
- Mild Dilatation of the Main Pancreatic Duct Is a Risk Factor for Progression to Pancreatic Cancer in High-Risk Individuals. Co-author DOI 10.1016/j.gastha.2025.100802↗
- Using Tumor Marker Gene Variants to Improve the Diagnostic Accuracy of DUPAN-2 and Carbohydrate Antigen 19-9 for Pancreatic Cancer. Co-author DOI 10.1200/jco.23.01573↗
- Using a CA19-9 Tumor Marker Gene Test to Assess Outcome After Pancreatic Cancer Surgery. Co-author DOI 10.1245/s10434-024-14942-5↗
Closest collaborators
The 25 strongest of 27 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Michael Goggins · 4 shared papers, 2024–2026 · strength 0.82
- Paper Mild Dilatation of the Main Pancreatic Duct Is a Risk Factor for Progression to Pancreatic Cancer in High-Risk Individu… DOI 10.1016/j.gastha.2025.100802↗
- Paper First-in-human testing of a mutant KRAS vaccine for pancreatic cancer interception in high-risk cohorts. DOI 10.1158/2159-8290.cd-25-2245↗
- Paper Using a CA19-9 Tumor Marker Gene Test to Assess Outcome After Pancreatic Cancer Surgery. DOI 10.1245/s10434-024-14942-5↗
- Jin Peng He · 3 shared papers, 2024–2025 · strength 0.62
- Paper Mild Dilatation of the Main Pancreatic Duct Is a Risk Factor for Progression to Pancreatic Cancer in High-Risk Individu… DOI 10.1016/j.gastha.2025.100802↗
- Paper Using a CA19-9 Tumor Marker Gene Test to Assess Outcome After Pancreatic Cancer Surgery. DOI 10.1245/s10434-024-14942-5↗
- Paper Using Tumor Marker Gene Variants to Improve the Diagnostic Accuracy of DUPAN-2 and Carbohydrate Antigen 19-9 for Pancre… DOI 10.1200/jco.23.01573↗
- Amanda L. Blackford · 3 shared papers, 2024–2025 · strength 0.62
- Paper Mild Dilatation of the Main Pancreatic Duct Is a Risk Factor for Progression to Pancreatic Cancer in High-Risk Individu… DOI 10.1016/j.gastha.2025.100802↗
- Paper Using a CA19-9 Tumor Marker Gene Test to Assess Outcome After Pancreatic Cancer Surgery. DOI 10.1245/s10434-024-14942-5↗
- Paper Using Tumor Marker Gene Variants to Improve the Diagnostic Accuracy of DUPAN-2 and Carbohydrate Antigen 19-9 for Pancre… DOI 10.1200/jco.23.01573↗
- Richard Andrew Burkhart · 3 shared papers, 2024–2025 · strength 0.62
- Paper Mild Dilatation of the Main Pancreatic Duct Is a Risk Factor for Progression to Pancreatic Cancer in High-Risk Individu… DOI 10.1016/j.gastha.2025.100802↗
- Paper Using a CA19-9 Tumor Marker Gene Test to Assess Outcome After Pancreatic Cancer Surgery. DOI 10.1245/s10434-024-14942-5↗
- Paper Using Tumor Marker Gene Variants to Improve the Diagnostic Accuracy of DUPAN-2 and Carbohydrate Antigen 19-9 for Pancre… DOI 10.1200/jco.23.01573↗
- Helena Saba · 3 shared papers, 2024–2025 · strength 0.62
- Paper Mild Dilatation of the Main Pancreatic Duct Is a Risk Factor for Progression to Pancreatic Cancer in High-Risk Individu… DOI 10.1016/j.gastha.2025.100802↗
- Paper Using a CA19-9 Tumor Marker Gene Test to Assess Outcome After Pancreatic Cancer Surgery. DOI 10.1245/s10434-024-14942-5↗
- Paper Using Tumor Marker Gene Variants to Improve the Diagnostic Accuracy of DUPAN-2 and Carbohydrate Antigen 19-9 for Pancre… DOI 10.1200/jco.23.01573↗
- Takeichi Yoshida · 3 shared papers, 2024–2026 · strength 0.58
- Paper First-in-human testing of a mutant KRAS vaccine for pancreatic cancer interception in high-risk cohorts. DOI 10.1158/2159-8290.cd-25-2245↗
- Paper Using a CA19-9 Tumor Marker Gene Test to Assess Outcome After Pancreatic Cancer Surgery. DOI 10.1245/s10434-024-14942-5↗
- Paper Using Tumor Marker Gene Variants to Improve the Diagnostic Accuracy of DUPAN-2 and Carbohydrate Antigen 19-9 for Pancre… DOI 10.1200/jco.23.01573↗
- Linda Chi Hang Chu · 2 shared papers, 2025–2026 · strength 0.45
- Paper Mild Dilatation of the Main Pancreatic Duct Is a Risk Factor for Progression to Pancreatic Cancer in High-Risk Individu… DOI 10.1016/j.gastha.2025.100802↗
- Paper First-in-human testing of a mutant KRAS vaccine for pancreatic cancer interception in high-risk cohorts. DOI 10.1158/2159-8290.cd-25-2245↗
- Marcia Irene Canto · 2 shared papers, 2024–2025 · strength 0.42
- Paper Mild Dilatation of the Main Pancreatic Duct Is a Risk Factor for Progression to Pancreatic Cancer in High-Risk Individu… DOI 10.1016/j.gastha.2025.100802↗
- Paper Using Tumor Marker Gene Variants to Improve the Diagnostic Accuracy of DUPAN-2 and Carbohydrate Antigen 19-9 for Pancre… DOI 10.1200/jco.23.01573↗
- Yohei Ando · 2 shared papers, 2024 · strength 0.37
- James R. Eshleman · 2 shared papers, 2024 · strength 0.37
- Ralph H. Hruban MD · 1 shared paper, 2025 · strength 0.25
- Dimitrios N. Sidiropoulos · 1 shared paper, 2026 · strength 0.21
- Hao Wang · 1 shared paper, 2026 · strength 0.21
- Saurav Daniel Haldar · 1 shared paper, 2026 · strength 0.21
- Marina Baretti · 1 shared paper, 2026 · strength 0.21
- Luciane Tsukamoto Kagohara · 1 shared paper, 2026 · strength 0.21
- Mark M. Yarchoan · 1 shared paper, 2026 · strength 0.21
- Matthew Z. Guo · 1 shared paper, 2026 · strength 0.21
- Hassan Sinan · 1 shared paper, 2026 · strength 0.21
- Neeha Zaidi · 1 shared paper, 2026 · strength 0.21
- Nilofer Saba Azad · 1 shared paper, 2026 · strength 0.21
- Elizabeth M. Jaffee · 1 shared paper, 2026 · strength 0.21
- Won Jin Ho · 1 shared paper, 2026 · strength 0.21
- Katherine M. Bever · 1 shared paper, 2026 · strength 0.21
- Amanda L. Huff · 1 shared paper, 2026 · strength 0.21
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.